Viewing nowCombinationBasta Tablet 10/10 (Ezetimibe, Simvastatin)
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Ilyun Pharmaceutical Co., Ltd.

MFDS item code 201601733 · Approved 2016.03.31 · Insurance code 658603350
Improvement of hypercholesterolemia (primary and homozygous familial) and mixed dyslipidemia
This drug is used as an adjunct to diet for lowering elevated total cholesterol and LDL-cholesterol, apoB protein, and triglycerides in patients with primary hypercholesterolemia and mixed dyslipidemia, while raising HDL-cholesterol levels. Additionally, it is administered as an adjunct when other lipid-lowering treatments are not effective in patients with homozygous familial hypercholesterolemia. This medication should be used together with an appropriate diet that includes restrictions on saturated fats and cholesterol, and applied when non-pharmacological measures are insufficiently effective. Prior to treatment, secondary causes such as diabetes, hypothyroidism, and chronic renal failure should be identified and treated if necessary. During treatment, regular lipid tests for total cholesterol, LDL, HDL, and triglycerides are essential, especially for acute coronary event patients, where testing should be done at the time of admission or within 24 hours. In summary, this drug is used to effectively control blood lipid levels associated with hypercholesterolemia to reduce cardiovascular risk.
Patients should follow a standard cholesterol-lowering diet before and during treatment with this medicine. The dosage should be adjusted according to the patient's baseline LDL cholesterol level, recommended treatment goal, and response. Take this medicine once daily in the evening, with or without food. Patients with primary hypercholesterolemia The dosage range is 10/10 mg to 10/40 mg once daily. The generally recommended starting dose is 10/20 mg once daily. Patients who require less LDL cholesterol reduction may start with 10/10 mg once daily. After starting treatment or adjusting the dose, adjust the dose after checking blood lipid levels at intervals of at least 4 weeks. Because of the increased risk of myopathy, including rhabdomyolysis, particularly during the first year of treatment, the 10/80 mg dose of this medicine should be used only in patients who have taken 10/80 mg for 12 months or longer without evidence of muscle toxicity (see 1. Warnings under Precautions for Use). Patients with homozygous familial hypercholesterolemia The recommended dose for patients with homozygous familial hypercholesterolemia is 10/40 mg once daily, taken in the evening. This medicine is used as an adjunct to other lipid-lowering treatments (e.g., LDL apheresis) or when other lipid-lowering treatments are not useful. Administration in patients with hepatic impairment No dosage adjustment is necessary in patients with mild hepatic impairment; however, use of this medicine is not recommended in patients with moderate or severe hepatic impairment (see 5. General Precautions, Patients with Abnormal Liver Function, under Precautions for Use). Administration in patients with renal impairment and patients with chronic kidney disease No dosage adjustment is necessary in patients with mild renal impairment (estimated glomerular filtration rate (GFR) ≥ 60mL/min/1.73㎡). In patients with chronic kidney disease and an estimated glomerular filtration rate < 60mL/min/1.73㎡, administer 10/20 mg once daily in the evening. Use caution and carefully monitor these patients when administering higher doses of this medicine (see 5. General Precautions under Precautions for Use). Administration in elderly patients No dosage adjustment is necessary in elderly patients. Concomitant use with other medicines (See 6. Interactions under Precautions for Use.) Administer this medicine at least 2 hours before or at least 4 hours after administration of a bile acid sequestrant. Patients taking this medicine concomitantly with verapamil, diltiazem, or dronedarone should not exceed 10/10 mg/day of this medicine. Patients taking this medicine concomitantly with amiodarone, amlodipine, or ranolazine should not exceed 10/20 mg/day of this medicine.
This drug may cause muscle-related side effects such as myopathy or rhabdomyolysis, so if muscle pain or weakness occurs, the patient must promptly inform their physician. The risk may increase when taking high doses or certain medications together. Patients with allergies to the components of this drug or those with liver diseases should not take it. Pregnant or breastfeeding women should not take this drug, and women planning to become pregnant should consult their physician. Furthermore, this drug should not be taken with strong CYP3A4 inhibitors such as certain antifungals, antibiotics, and antivirals. Special caution is also needed when co-administering with specific immunosuppressants or anticoagulants. Patients with liver function abnormalities or elevated liver enzymes should receive regular testing and immediately inform their physician of any unusual symptoms. Elderly patients or those with reduced renal function also require special management when taking this drug. It is advisable to avoid grapefruit juice while taking this drug, and to inform healthcare providers of this medication when starting other prescriptions. There is no specific antidote in case of overdose, and symptomatic treatment will be administered accordingly. This drug has not been adequately proven safe and effective in children, hence caution is advised when administering to pediatric patients.
Myopathy, rhabdomyolysis, elevated creatine kinase, headache, diarrhea, influenza, upper respiratory infection, myalgia, limb pain, fatigue, abdominal pain, viral infection, pharyngitis, sinusitis, arthralgia, low back pain, cough, anaphylaxis, urticaria, rash, angioedema, elevated liver aminotransferase levels, hepatitis, thrombocytopenia, nausea, pancreatitis, dizziness, sensory abnormalities, depression, cholelithiasis, cholecystitis, Stevens-Johnson syndrome, toxic epidermal necrolysis, eosinophilia, systemic drug reaction with symptoms, erythema multiforme, liver damage, myasthenia, cataract, constipation, dyspepsia, flatulence, nausea, eczema, pruritus, rash, muscle cramps, specific cranial nerve dysfunction, extraocular movement disorders, incomplete facial paralysis, tremor, peripheral neuropathy, peripheral nerve paralysis, mental disorders, anxiety, sleep disorders, memory decline, amnesia, memory loss, cognitive impairment, confusion, interstitial lung disease, lupus erythematosus-like syndrome, polymyositis, dermatomyositis, vasculitis, purpura, leukopenia, hemolytic anemia, positive antinuclear antibody, increased erythrocyte sedimentation rate, arthritis, fever, chills, flushing, malaise, dyspnea, cholestatic jaundice, liver fat changes, cirrhosis, fulminant hepatic necrosis, liver cancer, liver failure, anorexia, vomiting, alopecia, various skin changes, lichen planus-like drug rash, gynecomastia, decreased libido, sexual dysfunction, ocular muscle paralysis, anemia, elevated aminotransferases, elevated ALP, elevated γ-GT, increased bilirubin levels, thyroid dysfunction, increased HbA1c, increased fasting blood glucose levels, edema, thirst, facial swelling, syncope, insomnia, gastritis, atrophic gastritis, mucous stools, irritable bowel syndrome, sore throat, nocturia, hematuria, elevated serum creatine phosphokinase levels, weight loss
Not everyone experiences these, and they can vary from person to person.
This medication should be stored in a tightly closed container to protect it from air and moisture. Additionally, it is important to store it at a cool room temperature, between 1 and 30 degrees Celsius, to maintain the drug's effectiveness.
White to pale yellow, bilaterally convex rectangular tablet
30 tablets (10 tablets/PTP packaging x 3)
Even with the same ingredient, strength, dosage form and how it is taken can differ.
Viewing nowCombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Ilyun Pharmaceutical Co., Ltd.
CombinationSimvastatin 10mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 20mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
CombinationSimvastatin 40mg · Ezetimibe 10mg
Tablet · Prescription medication · Combination
Korea Organon Co., Ltd.
Ezetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
Ezetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Boryung Pharmaceutical Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 10mg
Tablet · Prescription medication · Combination
Suhung Co., Ltd.
CombinationEzetimibe 10mg · Simvastatin 20mg
Tablet · Prescription medication · Combination
Seohung Co., Ltd.
Even with the same ingredient, the dose and directions can differ by strength and dosage form. Talk to a doctor or pharmacist before switching from a medication you are already taking.
No questions yet.
For anything that needs medical judgment, consult a doctor or pharmacist.
This drug information is based on data provided by the Korea Ministry of Food and Drug Safety.
Consult a doctor or pharmacist for accurate dosage, administration, and usage instructions.